Key result
Telehealth pharmacist clinics linked to a ~13% absolute increase in OMT adherence 12 months post-ACS.
Why the study?
Adherence to secondary prevention medications following ACS predicts future major adverse cardiovascular events, but underutilisation remains a global issue.
Does a telehealth cardiology pharmacist clinic improve adherence to secondary prevention medications in patients following acute coronary syndrome?
Population
156 patients who received PCI for ACS
Comparison
Telehealth cardiology pharmacist clinic vs historical matched cohort without pharmacist clinic
Design
Retrospective matched cohort study within a large regional health service
Follow-up
12 months
Authors
Loading...
May support telehealth pharmacist roles post-ACS; hypothesis-generating and requires randomized confirmation before practice change.
Cohort (n=156)
No
Does a telehealth cardiology pharmacist clinic improve adherence to secondary prevention medications in patients following acute coronary syndrome?
Effect estimate: 13% absolute increase
Absolute Event Rate: 44% vs 31%
p-value: p=0.038
A telehealth cardiology pharmacist clinic significantly improves adherence to secondary prevention medications at 12 months following acute coronary syndrome.
Livori et al. (2023) conducted a cohort in Acute coronary syndrome (ACS) post percutaneous coronary intervention (PCI) (n=156). Telehealth cardiology pharmacist clinic vs. Standard care (historical control) was evaluated on Adherence to optimal medical therapy (all four groups of secondary prevention medications) at 12 months (13% absolute increase, p=0.038). A telehealth cardiology pharmacist clinic significantly increased adherence to optimal medical therapy at 12 months post-acute coronary syndrome by an absolute 13% compared to standard care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: